Name: Canine Atopic Dermatitis Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: VH4586
Price: 4350 USD
Availability: InStock

Canine Atopic Dermatitis Market Size Share Growth & Forecast 2023-30

Canine Atopic Dermatitis Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Canine Atopic Dermatitis Market is Segmented By Treatment Type (Monoclonal Antibody, Glucocorticoids, Immuno-suppressants, Other Treatment Types), By Route of Administration(Injectable, Topical, Oral), By Distribution Channel(Veterinary hospitals, Pet clinics, Pharmacies &amp; drug stores, Others),&nbsp;By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, &nbsp;2022-2029.</h2>

Canine Atopic Dermatitis Market&nbsp;is expected to reach&nbsp;at a <a href="https://www.datamintelligence.com/download-sample/canine-atopic-dermatitis-market">CAGR 8.46%</a> during the forecast period (2022-2029). Canine atopic dermatitis is the chronic inflammation on the skin of dogs, often caused by allergens such as pollens, flea or other insect bites, and food ingredients.

<h3>Canine Atopic Dermatitis Market Dynamics</h3>

The global canine atopic dermatitis market growth is driven by the rise in prevalence of canine atopic dermatitis, rise in awareness about early signs &amp; symptoms of allergic reaction in animals and development of advanced therapeutic methods to control symptoms, rise in pollution associated with allergens level.

Increasing R&amp;D activities is expected to drive the growth in the forecast period

Environmental factors are responsible for many allergies and diseases, expected to drive market growth. Increasing R&amp;D activities are also expected to drive the market. For instance, in January 2020, Boragen partnered with one of the global leading animal health companies, exclusively for the R&amp;D activity related to developing new treatment of canine atopic dermatitis. Also, as per the research article published in Veterinary Medicine and Science, 2020, Luteolin was evaluated to study the antioxidant effect in treating canine atopic dermatitis. The results revealed that Luteolin was able to drastically minimize the levels of IL‐33, IL 1&beta;, IL‐6, and IL‐8 and suggested that Luteolin is a promising agent in pharmacological treatment for canine atopic dermatitis. Hence, such factors are expected to boost the canine atopic dermatitis market during the forecast period.

Drug-induced severe hypersensitivity reactions are likely to hamper the market growth

Several drugs cause serious adverse reactions which can further alleviate allergic reactions. Improper management of canine atopic dermatitis in terms of dosage, administration of drugs, and drug combination can also hamper the growth of the global market.

<h3>COVID-19 Impact Analysis</h3>

The impact of COVID-19 on the canine atopic dermatitis market is expected to be significant. As per the Centers for Disease Control and Prevention data, cats, dogs, and a few other types of animals are at potential risk of acquiring this virus. Several studies are still ongoing concerning the connection between animals and human transmission of this virus. However, governments have been taking measures to mitigate the supply of medicines. For instance, the European Medicines Agency issued guidance for companies responsible for veterinary medicines regarding the adaptations to the regulatory framework, primarily to address the challenges faced during the pandemic. IN July 2020, the Centers for Disease Control and Prevention recommended certain guidelines to the veterinary professionals to treat companion animals during the COVID-19 pandemic.

Additionally, as per the research article published in Humanities and Social Sciences Communications, 2020, the total number of online searches on the Yad4 website was 221,959 in April 2020 compared to 72,703 in April 2019. The study revealed the growing rate of dog adoption during the pandemic. Therefore, the canine atopic dermatitis market is expected to be impacted during the pandemic due to such factors.

<h3>Canine Atopic Dermatitis Market Segment Analysis</h3>

The monoclonal antibodies segment is expected to hold the largest share in this market segment

The monoclonal antibodies segment is expected to exhibit profitable market growth over the forecast period. The major attributable factors are the rising awareness of biotherapeutics and the increasing product approvals.

Lokivetmab is a caninized anti&ndash;interleukin-31 (IL-31) mAb developed and licensed by Zoetis. It works by neutralizing soluble IL-31 released primarily by lymphocytes. Lokivetmab is effective against atopic dermatitis and allergic dermatitis in dogs. Furthermore, in 2019, Kindred Biosciences developed a monoclonal antibody, Interleukin-31, to treat canine atopic dermatitis. It completed its pilot study and showed a significant outcome. Hence, advancements in products are expected to influence the market positively.

As per the research article published in the Asian Journal of Epidemiology, 2020, the development of monoclonal antibodies is expected to show similar growth in veterinary medicine that aids in providing promising alternative strategies to overcome the obstacles of drug resistance, adverse effects of drugs, drug residue, and other complications associated with the traditional veterinary drugs. Thus, due to the aforementioned factors, therapeutic monoclonal antibodies are gaining importance in treating allergic conditions in dogs, which may boost market growth over the forecast period.

Canine Atopic Dermatitis Market

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			8.46%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Treatment Type,&nbsp;By Route of Administration,&nbsp;By Distribution Channel, and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

<h3>Canine Atopic Dermatitis Market Geographical Analysis</h3>

North America region holds the largest market share of the global canine atopic dermatitis market 

North America is expected to be a dominant region for the canine atopic dermatitis market, owing to increased spending in R&amp;D activities, the high concentration of key players in the market, and the high rate of households with dog ownership in the region. According to the Animal Health Institute, the US animal health industry serves around 640 million food animals and 383 million companion animals.

As per the Canadian Animal Health Institute (CAHI), in 2018, there were nearly 8.2 million dogs in Canada. Over a decade, dog ownership has increased significantly in the country. As per the American Pet Products Association, nearly 63.4 million households in the United States owned a dog in 2020. Additionally, dogs occupy 63.4% of the pet share in the United States, and owners spend an average of around USD 1,380 on pet dogs&rsquo; basic expenses. Thus, high dog ownership in the region is expected to drive market growth.

Also, the new product approvals and strategic alliances by key players are expected to boost the studied market. For instance, in October 2020, Elanco signed an agreement to acquire Bayer&rsquo;s Animal Health business in a transaction valued at USD 7.6 billion. Thus, the North American canine atopic dermatitis market is expected to register significant growth over the forecast period due to the factors mentioned above.

<h3>Canine Atopic Dermatitis Market Competitive Landscape</h3>

The global canine atopic dermatitis market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Zoetis, Elanco, Virbac, Toray Industries Inc., Dechra Veterinary Products, Kindred Biosciences Inc., Ceva, Vetoquinol S.A, Novartis AG. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market. For instance, in October 2020, Virbac received US FDA approval for its CYCLAVANCE (cyclosporine oral solution) USP MODIFIED to control atopic dermatitis in dogs weighing at least 4 lbs (1.8 kg).

Global Canine Atopic Dermatitis Market &ndash; Key Companies to Watch

Zoetis

Overview: Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. It includes seven product categories: vaccines, anti-infectives, parasiticides, dermatology products, medicated feed additives, animal health diagnostics, other pharmaceuticals.

Product Portfolio: CYTOPOINT is effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.

Key Developments: In September 2020, Zoetis received a variation to the terms of the marketing authorization for the veterinary medicinal product, Cytopoint, by the Committee for Medicinal Products for Veterinary Use (CVMP), in which the variation concerns adding a new therapeutic indication for the treatment of pruritus associated with allergic dermatitis in dogs.

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Frequently Asked Questions</h3>

What is the Projected CAGR value of the Canine Atopic Dermatitis Market?

Canine Atopic Dermatitis Market is expected to grow at a&nbsp;CAGR of 8.46%&nbsp;during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America&nbsp;region Controls&nbsp;the&nbsp;Canine Atopic Dermatitis Market&nbsp;during 2022-2029

Which is the fastest growing region in the Canine Atopic Dermatitis Market?

Among all regions,&nbsp;Asia Pacific&nbsp;is the fastest growing market share during the forecast period&nbsp;

<h3>&nbsp;</h3>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/animal-antibiotics-and-antimicrobials-market">Animal Antibiotics and Antimicrobials Market</a>

<a href="https://www.datamintelligence.com/research-report/veterinary-healthcare-market">Veterinary Healthcare Market</a>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet by Treatment Type</li>
		<li>Market Snippet by Route of Administration</li>
		<li>Market Snippet by Distribution Channel</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3>Global Canine Atopic Dermatitis Market-Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers:
			<ol>
				<li>Increasing R&amp;D activities</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Drug-induced severe hypersensitivity reactions</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Pipeline</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Treatment Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Attractiveness Index, By Treatment Type</li>
		</ol>
		</li>
		<li>Monoclonal Antibody*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Glucocorticoids</li>
		<li>Immuno-suppressants</li>
		<li>Other Treatment Types</li>
	</ol>
	</li>
	<li>
	<h3>By Route of Administration</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration</li>
		<li>Market Attractiveness Index, By Route of Administration</li>
		<li>Injectable*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Topical</li>
		<li>Oral</li>
	</ol>
	</li>
	<li>
	<h3>By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel</li>
		</ol>
		</li>
		<li>Veterinary hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Pet clinics</li>
		<li>Pharmacies &amp; drug stores</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
		<li>Key Companies to Watch</li>
		<li>Company with disruptive technology</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>Zoetis*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Elanco</li>
		<li>Virbac</li>
		<li>Toray Industries Inc</li>
		<li>Dechra Veterinary Products</li>
		<li>Kindred Biosciences Inc</li>
		<li>Ceva</li>
		<li>Vetoquinol S.A</li>
		<li>Novartis AG(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3>DataM Intelligence&nbsp;&nbsp;</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 1&nbsp;Global Canine Atopic Dermatitis Market Value, By Treatment Type, 2021, 2025 &amp; 2029 ($ Million)

Table 2&nbsp;Global Canine Atopic Dermatitis Market Value, By Route of Administration, 2021, 2025 &amp; 2029 ($ Million)

Table 3&nbsp;Global Canine Atopic Dermatitis Market Value, By Distribution Channel, 2021, 2025 &amp; 2029 ($ Million)

Table 4&nbsp;Global Canine Atopic Dermatitis Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 5&nbsp;Global Canine Atopic Dermatitis Market Value, By Treatment Type, 2021, 2025 &amp; 2029 ($ Million)

Table 6&nbsp;Global Canine Atopic Dermatitis Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 7&nbsp;Global Canine Atopic Dermatitis Market Value, By Route of Administration, 2021, 2025 &amp; 2029 ($ Million)

Table 8&nbsp;Global Canine Atopic Dermatitis Market Value, By Route of Administration, 2019-2029 ($ Million)

Table 9&nbsp;Global Canine Atopic Dermatitis Market Value, By Distribution Channel, 2021, 2025 &amp; 2029 ($ Million)

Table 10&nbsp; Global Canine Atopic Dermatitis Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 11&nbsp; Global Canine Atopic Dermatitis Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 12&nbsp; Global Canine Atopic Dermatitis Market Value, By Region, 2019-2029 ($ Million)

Table 13&nbsp; North America Canine Atopic Dermatitis Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 14&nbsp; North America Canine Atopic Dermatitis Market Value, By Route of Administration, 2019-2029 ($ Million)

Table 15&nbsp; North America Canine Atopic Dermatitis Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 16&nbsp; North America Canine Atopic Dermatitis Market Value, By Country, 2019-2029 ($ Million)

Table 17&nbsp; South America Canine Atopic Dermatitis Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 18&nbsp; South America Canine Atopic Dermatitis Market Value, By Route of Administration, 2019-2029 ($ Million)

Table 19&nbsp; South America Canine Atopic Dermatitis Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 20 South America Canine Atopic Dermatitis Market Value, By Country, 2019-2029 ($ Million)

Table 21&nbsp; Europe Canine Atopic Dermatitis Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 22 Europe Canine Atopic Dermatitis Market Value, By Route of Administration, 2019-2029 ($ Million)

Table 23 Europe Canine Atopic Dermatitis Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 24 Europe Canine Atopic Dermatitis Market Value, By Country, 2019-2029 ($ Million)

Table 25 Asia-Pacific Canine Atopic Dermatitis Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 26 Asia-Pacific Canine Atopic Dermatitis Market Value, By Route of Administration, 2019-2029 ($ Million)

Table 27 Asia-Pacific Canine Atopic Dermatitis Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 28 Asia-Pacific Canine Atopic Dermatitis Market Value, By Country, 2019-2029 ($ Million)

Table 29 Middle East &amp; Africa Canine Atopic Dermatitis Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 30 Middle East &amp; Africa Canine Atopic Dermatitis Market Value, By Route of Administration, 2019-2029 ($ Million)

Table 31&nbsp; Middle East &amp; Africa Canine Atopic Dermatitis Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 32 Elanco: Overview

Table 33 Elanco: Product Portfolio

Table 34 Elanco: Key Developments

Table 35 Virbac: Overview

Table 36 Virbac: Product Portfolio

Table 37 Virbac: Key Developments

Table 38 Toray Industries Inc: Overview

Table 39 Toray Industries Inc: Product Portfolio

Table 40 Toray Industries Inc: Key Developments

Table 41&nbsp; Dechra Veterinary Products: Overview

Table 42 Dechra Veterinary Products: Product Portfolio

Table 43 Dechra Veterinary Products: Key Developments

Table 44 Kindred Biosciences Inc: Overview

Table 45 Kindred Biosciences Inc: Product Portfolio

Table 46 Kindred Biosciences Inc: Key Developments

Table 47 Ceva: Overview

Table 48 Ceva: Product Portfolio

Table 49 Ceva: Key Developments

Table 50 Vetoquinol S.A: Overview

Table 51&nbsp; Vetoquinol S.A: Product Portfolio

Table 52 Vetoquinol S.A: Key Developments

Table 53 Novartis AG: Overview

Table 54 Novartis AG: Product Portfolio

Table 55 Novartis AG: Key Developments

Table 56 Zoetis: Overview

Table 57 Zoetis: Product Portfolio

Table 58 Zoetis: Key Developments

List of Figures

Figure 1&nbsp; Global Canine Atopic Dermatitis Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 2&nbsp; Global Canine Atopic Dermatitis Market Share, By Route of Administration, 2021 &amp; 2029 (%)

Figure 3&nbsp; Global Canine Atopic Dermatitis Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 4 Global Canine Atopic Dermatitis Market Share, By Region, 2021 &amp; 2029 (%)

Figure 5&nbsp; Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 6 Global Canine Atopic Dermatitis Market Y-o-Y Growth, By Treatment Type, 2021-2029 (%)

Figure 7&nbsp; Glucocorticoids: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 8 Immuno-suppressants: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 9 Monoclonal Antibody: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 10 Other Treatment Types: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 11 Global Canine Atopic Dermatitis Market Y-o-Y Growth, By Route of Administration, 2021-2029 (%)

Figure 12&nbsp; Oral: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 13&nbsp; Topical: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 14 Injectable: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 15&nbsp; Global Canine Atopic Dermatitis Market Y-o-Y Growth, By Distribution Channel, 2021-2029 (%)

Figure 16 Veterinary hospitals: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 17&nbsp; Pet clinics: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 18 Pharmacies &amp; drug stores: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 19 Others: Global Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 20 Global Canine Atopic Dermatitis Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 21&nbsp; North America Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 22 North America Canine Atopic Dermatitis Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 23 North America Canine Atopic Dermatitis Market Share, By Route of Administration, 2021 &amp; 2029 (%)

Figure 24 North America Canine Atopic Dermatitis Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 25 North America Canine Atopic Dermatitis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 26 South America Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 27 South America Canine Atopic Dermatitis Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 28 South America Canine Atopic Dermatitis Market Share, By Route of Administration, 2021 &amp; 2029 (%)

Figure 29 South America Canine Atopic Dermatitis Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 30 South America Canine Atopic Dermatitis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 31&nbsp; Europe Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 32 Europe Canine Atopic Dermatitis Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 33 Europe Canine Atopic Dermatitis Market Share, By Route of Administration, 2021 &amp; 2029 (%)

Figure 34 Europe Canine Atopic Dermatitis Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 35 Europe Canine Atopic Dermatitis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 36 Asia-Pacific Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 37 Asia-Pacific Canine Atopic Dermatitis Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 38 Asia-Pacific Canine Atopic Dermatitis Market Share, By Route of Administration, 2021 &amp; 2029 (%)

Figure 39 Asia-Pacific Canine Atopic Dermatitis Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 40 Asia-Pacific Canine Atopic Dermatitis Market Share, By Country, 2021 &amp; 2029 (%)

Figure 41 Middle East &amp; Africa Canine Atopic Dermatitis Market Value, 2019-2029 ($ Million)

Figure 42 Middle East &amp; Africa Canine Atopic Dermatitis Market Share, By Treatment Type, 2021 &amp; 2029 (%)

Figure 43 Middle East &amp; Africa Canine Atopic Dermatitis Market Share, By Route of Administration, 2021 &amp; 2029 (%)

Figure 44 Middle East &amp; Africa Canine Atopic Dermatitis Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 45 Elanco: Financials

Figure 46 Virbac: Financials

Figure 47 Toray Industries Inc: Financials

Figure 48 Dechra Veterinary Products: Financials

Figure 49 Kindred Biosciences Inc: Financials

Figure 50 Ceva: Financials

Figure 51&nbsp; Vetoquinol S.A: Financials

Figure 52 Novartis AG: Financials

Figure 53 Zoetis: Financials